Summary:The neuroprotective action of brain-derived neurotrophic factor (BDNF) was evaluated in a rat model of transient forebrain ischemia. A continuous intraven tricular infusion of BDNF for 7 days starting immediately before the onset of ischemia significantly increased the number of pyramidal cells in the vulnerable CA 1 sector of Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin gene family (Leibrock et aI., 1989) that acts as a potent survival factor for some neuronal populations in culture (Johnson et aI. , 1986; Alderson et aI., 1990; Hyman et aI., 199 1; Kniisel et aI., 199 1). In vivo, BDNF has been shown to increase the number of sensory neurons in the dorsal root and nodose ganglion of developing quails (Hofer and Barde, 1988) and to support the survival of motoneurons in the facial nerve after axotomy (Sendtner et aI., 1992 trkB receptors in the brain, suggests a therapeutic potential for BDNF in cerebral ischemia.
MATERIALS AND METHODSMale Wi star rats received continuous intraventricular infusions of BDNF starting immediately before the induc tion of ischemia and ending 7 days later. Rats (320-350 g) were fasted overnight, anesthetized with 1-2% halothane in a 70:30 mixture of nitrous oxide/oxygen, and placed in a David Kopf stereotaxic apparatus. A cannula device connected to a subcutaneously implanted miniosmotic pump (Alzet model 2001, Palo Alto, CA, U.S.A.) was inserted in the lateral ventricle at -0.4 mm to the bregma, 1.4 mm lateral to the midline, and 3.5 mm below the dura and fixed with dental cement and stainless-steel screws to the skull. Recombinant BDNF was delivered intraventricularly at a rate of 0.013 ILg/h dissolved in ster ile artificial cerebrospinal fluid containing 0.1% autolo gous rat serum as the carrier protein. Controls received similar infusions of the vehicle alone. Infusion was started 60-90 min before the induction of ischemia. Reg ular delivery of the pumps was checked at the end of infusion.Transient forebrain ischemia was induced in artificially ventilated rats (1-1.5% halothane in a 30:70 (vol/vol) mix ture of N20 and 02) according to Smith et al. (1984). A silicon catheter for withdrawal of blood was inserted in the jugular vein and advanced into the inferior caval vein. After discontinuation of halothane, muscle paralysis was maintained with suxamethonium chloride (courtesy of Dr. B. Kutscher, Asta Pharma, Frankfurt, Germany) and 690 T. BECK ET AL. blood clotting prevented by heparin (200 IU/kg). Needle electrodes were placed in the temporalis muscle for EEG recording. After stabilization of physiological parameters for 30 min, 5 mg/kg trimetaphan (Hoffmann-LaRoche, Grenzach-Wyhlen, Germany) was injected, the carotid arteries were clamped, and the blood pressure was low ered to 40 mm Hg by withdrawal of blood. The onset of an isoelectric EEG was taken as the indicator of ischemia. Blood pressure was recorded with a pressure transducer connected to the tail artery cannula. After 10 min, the carotid clamps were released and the shed blood w...